Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys and Copegus Induction Dosing in Chronic Hepatitis C Genotype 1
NCT00192647Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2004
- Primary completion
- Mar 2009
- Modality
- Cytokines & Interferons
- Countries
- 6
01
Overview
A Phase 4 trial of pegylated interferon alpha in hepatitis C virus infection, sponsored by Roche. Started Aug 2004; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00192647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192647.